drugset / Trial / NCT00002574
Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of homoharringtonine and interferon alfa in treating patients with chronic myelogenous leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Interferon alfa may interfere with the growth of cancer cells. Combining chemotherapy with interferon alfa may kill more cancer cells.
Timeline
- Start
- 1994-09
- Primary completion
- 2001-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Homoharringtonine | Small molecule | — | — |
| Subject | recombinant interferon alfa | Protein / enzyme biologic | — | — |